List of works - Chi Young Ok

EBV-positive diffuse large B-cell lymphoma of the elderly

scientific article

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

scientific article

Checkpoint inhibitors in hematological malignancies

scientific article

EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management

scientific article

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

scientific article

Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms

scientific article published on May 14, 2012

Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms

scientific article

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

scientific article

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

scientific article

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

scientific article

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

scientific article

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

scientific article published on 19 March 2014

High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome

scientific article published on 21 November 2014

Targeting the programmed death-1 pathway in lymphoid neoplasms.

scientific article published on 11 February 2017

Evaluation of an Automated Digital Imaging System, Nextslide Digital Review Network, for Examination of Peripheral Blood Smears

scientific article published on June 1, 2012

Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations

scientific article published on 26 September 2018

Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With αβ T-Cell Large Granular Lymphocytic Leukemia. [corrected].

scientific article

Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype

scientific article published on 19 September 2017

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib

scientific article published on 02 September 2018

Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing

scientific article published on 3 January 2018

The Oncofetal Protein IMP3: A Novel Molecular Marker to Predict Aggressive Meningioma

scientific article published on August 1, 2011

NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

scientific article

Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.

scientific article published on 22 January 2016

Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption

scientific article published on 04 August 2018

Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients

scientific article published on 26 June 2019

Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection

scientific article published on 01 January 2019

Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations

scientific article published on 11 March 2019

Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments

scientific article published on 28 March 2019

Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group

scientific article published on 18 April 2019

American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma

scientific article published on 06 February 2019

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma

scientific article published on 04 September 2018

Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy

scientific article published on 22 May 2019

Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?

scientific article published on 2 January 2014

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease

scientific article published on 07 May 2019

Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment

scientific article published on 08 May 2018

Single-Cell Quantitative PCR: Advances and Potential in Cancer Diagnostics

scientific article published on 01 January 2016

Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts

scientific article published on 17 September 2019

Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases

scientific article published in December 2021

Characterization of TP53 mutations in clonal cytopenia of undetermined significance.

scientific article

Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis

scientific article published in July 2017

Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time

scientific article published in March 2025

Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1

scientific article published on 01 April 2020

Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes

scientific article published in September 2022

Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features

scientific article

Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entity

scientific article published on 02 March 2014

Age cutoff in lymphoma diagnosis.

scientific article published on 6 July 2015

Transient/reversible ring sideroblasts in bone marrow of patients post cytotoxic therapies for primary malignancies

scientific article published on 18 May 2011

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

scientific article published on 10 January 2022

EZH2 expression is associated with inferior overall survival in mantle cell lymphoma

scientific article published in December 2021

Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease

scientific article published in December 2021

List of works by Chi Young Ok

EBV-positive diffuse large B-cell lymphoma of the elderly

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

Checkpoint inhibitors in hematological malignancies

EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms

Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome

Targeting the programmed death-1 pathway in lymphoid neoplasms.

Evaluation of an Automated Digital Imaging System, Nextslide Digital Review Network, for Examination of Peripheral Blood Smears

Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations

Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With αβ T-Cell Large Granular Lymphocytic Leukemia. [corrected].

Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib

Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing

The Oncofetal Protein IMP3: A Novel Molecular Marker to Predict Aggressive Meningioma

NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.

Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption

Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients

Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection

Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations

Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments

Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group

American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma

Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy

Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease

Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment

Single-Cell Quantitative PCR: Advances and Potential in Cancer Diagnostics

Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts

Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases

Characterization of TP53 mutations in clonal cytopenia of undetermined significance.

Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis

Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time

Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1

Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes

Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features

Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entity

Age cutoff in lymphoma diagnosis.

Transient/reversible ring sideroblasts in bone marrow of patients post cytotoxic therapies for primary malignancies

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

EZH2 expression is associated with inferior overall survival in mantle cell lymphoma

Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease